Francesca R. Ogliari

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer.

AI-HOPE lung cancer: a multicenter real-world registry integrating artificial intelligence for metastatic non-small-cell lung cancer.

Journal: ESMO real world data and digital oncology

Published: August 14, 2026

Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.

Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies.

Journal: The Lancet. Respiratory medicine

Published: May 26, 2026

EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the 'Rebiopsy on osi' Study).

EGFR-mutant NSCLC progressing on first-line osimertinib: rebiopsy in real-world and impact of second-line therapies (the 'Rebiopsy on osi' Study).

Journal: The oncologist

Published: February 11, 2026

Antibody-Drug Conjugates in Non-small Cell Lung Cancer.

Antibody-Drug Conjugates in Non-small Cell Lung Cancer.

Journal: Drugs

Published: January 15, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer

Published: January 11, 2026

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.

Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study.

Journal: Frontiers in oncology

Published: October 13, 2025

Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry.

Overall survival in patients with non-small cell lung cancer and leptomeningeal metastases: Data from the Dutch cancer Registry.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 23, 2025

Powering responsible artificial intelligence with high-quality real-world data: the S-RACE platform for scalable, multi-specialty clinical research.

Powering responsible artificial intelligence with high-quality real-world data: the S-RACE platform for scalable, multi-specialty clinical research.

Journal: NPJ digital medicine

Published: August 01, 2025

A viable human lung cancer tissue collection (LCTC) to accelerate translational research.

A viable human lung cancer tissue collection (LCTC) to accelerate translational research.

Journal: Cancer treatment and research communications

Published: July 21, 2025

Smaller, cheaper, faster: where next for liquid biopsies?

Smaller, cheaper, faster: where next for liquid biopsies?

Journal: Expert review of molecular diagnostics

Published: July 14, 2025

Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective study.

Association of metabolic tumour volume (MTV) and total lesion glycolysis (TLG) with survival in patients with oligometastatic non-small-cell lung cancer treated with immunotherapy: a multicentre retrospective study.

Journal: European journal of nuclear medicine and molecular imaging

Published: July 04, 2025

Can the positive findings from POD1UM-304 improve patient care worldwide?

Can the positive findings from POD1UM-304 improve patient care worldwide?

Journal: The Lancet. Respiratory medicine

Published: July 03, 2025

Showing 1-12 of 29

Last Updated: 09/26/2026